相似文献
1
Overprescribing proton pump inhibitors.
BMJ. 2008 Jan 5;336(7634):2-3. doi: 10.1136/bmj.39406.449456.BE.
2
Missing PPI prescriptions while overprescribing?
Eur J Clin Pharmacol. 2023 Nov;79(11):1579-1581. doi: 10.1007/s00228-023-03564-7. Epub 2023 Sep 19.
3
General Practice Research Database for prescribing analysis.
Lancet. 1998 Feb 7;351(9100):453-4. doi: 10.1016/S0140-6736(05)78411-7.
4
Proton pump inhibitors: why this gap between guidelines and prescribing practices in geriatrics?
Eur J Clin Pharmacol. 2019 Sep;75(9):1327-1329. doi: 10.1007/s00228-019-02692-3. Epub 2019 May 25.
5
Prescribing PPIs.
Drug Ther Bull. 2017 Oct;55(10):117-120. doi: 10.1136/dtb.2017.10.0541.
6
Overprescribing PPIs: An old problem.
BMJ. 2008 Jan 19;336(7636):109. doi: 10.1136/bmj.39458.462338.3A.
7
[Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?].
Rev Med Interne. 2015 Oct;36(10):651-7. doi: 10.1016/j.revmed.2015.04.014. Epub 2015 Jun 4.
8
Putting proton pump inhibitors into perspective.
Geriatr Nurs. 2017 Nov-Dec;38(6):589-590. doi: 10.1016/j.gerinurse.2017.10.006. Epub 2017 Nov 11.
9
[Practices evaluation of prescription of proton pump inhibitors in pharmacy].
Therapie. 2019 Dec;74(6):682-685. doi: 10.1016/j.therap.2019.04.004. Epub 2019 Apr 13.
10
[Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
Rev Med Interne. 2007 Feb;28(2):86-93. doi: 10.1016/j.revmed.2006.09.030. Epub 2006 Oct 20.
引用本文的文献
1
Artificial intelligence-assisted quality control circles led by clinical pharmacists to improve the rational use of parenteral proton pump inhibitors among hospitalised patients.
Sci Rep. 2025 Aug 26;15(1):31391. doi: 10.1038/s41598-025-16934-1.
2
Proton Pump Inhibitor Use and Risk of Clostridioides difficile Infection: An Umbrella Review of 11 Meta-Analyses.
Cureus. 2025 Jul 6;17(7):e87383. doi: 10.7759/cureus.87383. eCollection 2025 Jul.
3
Factors associated with drug-drug interactions involving citalopram in the UK Biobank.
BJPsych Open. 2025 Aug 1;11(5):e166. doi: 10.1192/bjo.2025.10060.
4
Perceived risk of gastric cancer associated with long-term use of proton pump inhibitors: Bridging the gap.
World J Clin Oncol. 2025 Jul 24;16(7):107091. doi: 10.5306/wjco.v16.i7.107091.
5
Association between preoperative proton pump inhibitor use and postoperative infectious and renal complications following major elective surgery.
Can J Surg. 2025 Jul 15;68(4):E305-E312. doi: 10.1503/cjs.010224. Print 2025 Jul-Aug.
6
Bone health, renal outcomes, and iron deficiency anaemia in proton pump inhibitor versus histamine-2 receptor antagonist users: a retrospective cohort study based on TriNetX global collaborative network data.
BMJ Open Gastroenterol. 2025 Jul 13;12(1):e001723. doi: 10.1136/bmjgast-2024-001723.
7
Appropriate Use of Proton Pump Inhibitors in General Out Patient Department of a Tertiary Care Center of Kathmandu Valley: An Observational Study.
JNMA J Nepal Med Assoc. 2025 Mar;63(283):149-153. doi: 10.31729/jnma.8913. Epub 2025 Mar 31.
8
Trends in Proton-Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015-2023.
Basic Clin Pharmacol Toxicol. 2025 Jun;137(1):e70057. doi: 10.1111/bcpt.70057.
9
Proton Pump Inhibitor Use Exceeding the U.S. Food and Drug Administration Approved Treatment Duration for Patients With Peptic Ulcer Disease: A Retrospective Cohort Study.
Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70152. doi: 10.1002/pds.70152.
10
Proton pump inhibitors and 1-year risk of adverse outcomes after discharge from internal medicine wards: an observational study in the REPOSI cohort.
Intern Emerg Med. 2025 Apr 6. doi: 10.1007/s11739-025-03937-z.
本文引用的文献
1
Inappropriate prescribing of proton pump inhibitors in primary care.
Postgrad Med J. 2007 Jan;83(975):66-8. doi: 10.1136/pgmj.2006.051151.
2
Long-term proton pump inhibitor therapy and risk of hip fracture.
JAMA. 2006 Dec 27;296(24):2947-53. doi: 10.1001/jama.296.24.2947.
3
Continuation of proton pump inhibitors from hospital to community.
Pharm World Sci. 2006 Aug;28(4):189-93. doi: 10.1007/s11096-006-9028-4. Epub 2006 Oct 26.
4
Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Aliment Pharmacol Ther. 2006 Sep 15;24(6):945-54. doi: 10.1111/j.1365-2036.2006.03084.x.
5
Acid suppressive therapy use on an inpatient internal medicine service.
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1261-6. doi: 10.1345/aph.1G703. Epub 2006 Jun 27.
6
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
JAMA. 2005 Dec 21;294(23):2989-95. doi: 10.1001/jama.294.23.2989.
7
Proton pump inhibitors: a survey of prescribing in an Irish general hospital.
Int J Clin Pract. 2005 Jan;59(1):31-4. doi: 10.1111/j.1742-1241.2004.00298.x.
8
An evaluation of the use of proton pump inhibitors.
Pharm World Sci. 2001 Jun;23(3):116-7. doi: 10.1023/a:1011278030001.
9
Overuse of proton pump inhibitors.
J Clin Pharm Ther. 2000 Oct;25(5):333-40. doi: 10.1046/j.1365-2710.2000.00312.x.
Zotero 插件